Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions
Status:
Completed
Trial end date:
2001-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the relative bioavailability of Ribavirin 200
capsules and Rebetol 200 mg capsules in females under fasting conditions.